MedTrace Logo

Peer Comparison Feedback As An Antimicrobial Prescribing Intervention To General Medicine Specialists

NCT07189364 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 650

Last updated 2026-05-05

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of a peer comparison feedback report, combined with a best practices toolkit, on the volume of antimicrobial use by general medicine physicians. The study also aims to understand the qualitative and quantitative impact of peer comparison feedback on antimicrobial prescribing in hospital.

This study will leverage data from GEMINI, a hospital research collaborative that collects administrative and clinical data from 30+ Ontario hospitals, to create these peer comparison feedback reports.

Conditions

  • Antimicrobial Stewardship
  • Antimicrobial Drug Resistance

Interventions

BEHAVIORAL

Peer Comparison Feedback Report

The intervention will be an electronic, individualized, peer-comparison feedback report on the participant's antimicrobial prescribing practices, combined with a knowledge toolkit focused on optimizing antimicrobial use.

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Sinai Health System

    collaborator OTHER

  • Unity Health Toronto

    collaborator OTHER

  • Fahad Razak

    lead OTHER

Principal Investigators

  • Fahad Razak, MD · St. Michael's Hospital - Unity Health Toronto

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2027-01-31
Completion
2027-04-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07189364 on ClinicalTrials.gov